HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a large-animal human brain tumor xenograft model in immunosuppressed cats.

Abstract
A large-animal model was developed to facilitate the noninvasive investigation of the effect on the human glioma-derived D-54 MG (glioblastoma multiforme) continuous cell line of a variety of therapeutic regimens. Twenty random-bred male cats were inoculated intracerebrally with 1 x 10(7) D-54 MG tumor cells after being initiated on one of three preparatory regimens of cyclosporin A p.o. Reproducible success of D-54 MG xenotransplantation (100%, 6 of 6 cats) was achieved only after pretreatment with 120 mg cyclosporin A p.o. (24-30 mg/kg) daily for greater than or equal to 10 days prior to tumor implantation. High-performance liquid chromatography-derived whole blood cyclosporin A 12-h trough levels of greater than or equal to 640 ng/ml were seen in successful implants. Lesions ranging from 2 to 20 mm in diameter were seen in cats sacrificed 27-44 days after implantation with no growth seen in control animals. Histopathological examination revealed the tumors to be well-circumscribed anaplastic intracerebral tumors with some invasion into surrounding host parenchyma. Perivascular lymphocytic cuffing was observed, but intratumoral lymphocytic infiltration was minimal. Gadolinium-EDTA-enhanced nuclear magnetic resonance imaging provided accurate tumor localization in T1-weighted images (TE 26 ms; TR 600 ms). Biochemical tests of kidney, liver, and hematological function were within normal limits, although 10% (2 of 20) of the animals developed gingival hyperplasia, and 5% (1 of 20) developed intussusception. The reproducible growth of the D-54 MG human glioblastoma cell line in a large-animal model eliminates many of the limitations associated with the standard nude mouse/rat model, thereby providing a novel test bed for a variety of imaging modalities as well as for drug immunoconjugate localization and toxicity studies.
AuthorsB W Krushelnycky, M A Farr-Jones, B Mielke, J D McKean, B K Weir, K C Petruk
JournalCancer research (Cancer Res) Vol. 51 Issue 9 Pg. 2430-7 (May 01 1991) ISSN: 0008-5472 [Print] United States
PMID2015604 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclosporins
Topics
  • Animals
  • Brain Neoplasms (diagnosis, genetics, pathology)
  • Cats
  • Cyclosporins
  • Disease Models, Animal
  • Glioma (diagnosis, genetics, pathology)
  • Humans
  • Immune Tolerance
  • Karyotyping
  • Magnetic Resonance Imaging
  • Male
  • Neoplasm Transplantation
  • Rhabdomyosarcoma (diagnosis, genetics, pathology)
  • Tumor Cells, Cultured (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: